Conspectus This Account is the first comprehensive review article on the newly developed,
photochemistry-based cancer therapy near-infrared (NIR) photoimmunotherapy (PIT). NIR …

The development of photoactive and biocompatible nanomaterials is a current major
challenge of materials science and nanotechnology, as they will contribute to promoting …

Near-infrared photoimmunotherapy (NIR-PIT) is a recently developed hybrid cancer therapy
that directly kills cancer cells as well as producing a therapeutic host immune response …

Near infrared photoimmunotherapy (NIR-PIT) is a newly developed molecular targeted
cancer treatment, which selectively kills cancer cells or immune-regulatory cells and induces …

Near-infrared photoimmunotherapy (NIR-PIT) is a newly-developed, highly-selective cancer
treatment, which utilizes a monoclonal antibody conjugated to a photoabsorbing dye …

The epidermal growth factor receptor (EGFR) plays a pivotal role in the proliferation and
metastatization of cancer cells. Aberrancies in the expression and activation of EGFR are …

Photoimmunotherapy (PIT) is a new cancer treatment that combines the specificity of
antibodies for targeting tumors with the toxicity induced by photosensitizers after exposure to …

Lung metastases are a leading cause of cancer related deaths; nonetheless current
treatments are limited. Near infrared photoimmunotherapy (NIR-PIT) is a new cancer …

The conventional treatment of thoracic tumors includes surgery, anticancer drugs, radiation,
and cancer immunotherapy. Light therapy for thoracic tumors has long been used as an …

Small cell lung cancer (SCLC), one of the most aggressive cancers, has a high mortality rate
and poor prognosis, and the clinical therapeutic outcomes of multidrug resistant SCLC are …